Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Phys Clinical Casesrenal

Phys Clinical Cases · renal

Renal Cell Carcinoma AND Urothelial Malignancy — DCE Clinical Case

DCE long-case and short-case station for Renal Cell Carcinoma AND Urothelial Malignancy.

1 min readVerification in progress

Target exams

FRACP DCEMRCP PACES
On this page
Study tools

Target exams

FRACP DCEMRCP PACES
Prompt
DCE long-case and short-case station for Renal Cell Carcinoma AND Urothelial Malignancy.

Renal Cell Carcinoma AND Urothelial Malignancy — Clinical Case

DCE Long Case

Patient brief

Patient: A middle-aged or older adult with multimorbidity and a presentation centred on Renal Cell Carcinoma AND Urothelial Malignancy. [1]

Presenting complaint: Subacute or acute symptoms referable to Renal Cell Carcinoma AND Urothelial Malignancy, with enough detail to force prioritisation. [1] [2]

Past history: Common cardiometabolic and organ comorbidities that interact with the plan. [2]

Medications: A polypharmacy list that includes at least one interaction or dosing issue. [2]

Examination: Key positives and critical negatives for dangerous differentials. [1]

Investigations: A small set of results that change management. [1] [2]

Tasks

  1. Present a prioritised problem list. [1]
  2. Defend investigations and immediate therapy. [1] [2]
  3. Provide safety-net and follow-up advice. [2]

Model discussion points

  • Working diagnosis and acuity. [1]
  • Differentials and discriminators. [2]
  • Treatment sequence and monitoring. [1] [2] [3]
  • Multimorbidity and communication. [2]
Physician Medicine Pro

Continue reading

You have read the opening of this clinical case. The complete unit — every section and its primary-source references — is part of the Physician Medicine fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Chen YS, Yu CC, Chang R, Wu SH, et al. Efficacy of checkpoint inhibitors in genitourinary cancers with advanced chronic kidney disease Cancer Immunol Immunother, 2026.PMID 42426360
  2. [2]Petrelli F, Colombo Zefinetti L, D'Alessio A, Dottorini L, et al. Next-Generation Checkpoint Combinations: Optimizing PD-(L)1-Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant Settings Curr Oncol Rep, 2026.PMID 42406187
  3. [3]Zhang Y, Wu G, Sun F, Wang B, et al. Radiomics and deep learning in upper tract urothelial carcinoma: advancing preoperative risk stratification and clinical decision-making Front Oncol, 2026.PMID 42404222
  4. [4]Jost LM, Duwe G, Kauth V, Höfner T, et al. [Artificial intelligence as decision support tool in urological oncology: current evidence and challenges] Urologie, 2026.PMID 42126599
  5. [5]Inoue S, Tsuboi I, Miszczyk M, Miyajima K, et al. Time-of-Day Immunotherapy Administration and Outcomes in Advanced Cancers: A Systematic Review and Meta-Analysis JAMA Netw Open, 2026.PMID 42084869
  6. [6]Maráz A, Koroncziová K, Rozsvai T [Immunotherapy for urological cancers in 2025] Magy Onkol, 2025.PMID 41385769
Physician Medicine Pro

$29/ monthor $279 / year

The complete Physician Medicine library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousPotassium Disorders — DCE Clinical CaserenalNextRenal Replacement Therapy (Haemodialysis, Peritoneal Dialysis) — DCE Clinical Caserenal